Hao Zhao

4PUBLICATIONS
11CO-AUTHORS
Regenerative medicine (incl. stem cells)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Medical biochemistry - lipids
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|May 01, 2024
Sirolimus is effective for refractory/relapsed idiopathic multicentric Castleman disease: A single-center, retrospective study.

Yan-Ting Liu, Yu-Han Gao, Hao Zhao

|Mar 28, 2024
A prospective study of zanubrutinib, a Bruton tyrosine kinase inhibitor, in relapsed/refractory idiopathic multicentric Castleman disease.

Lu Zhang, Yu-Han Gao, Si-Yuan Li

|Mar 17, 2023
A phase 2 prospective study of bortezomib, cyclophosphamide, and dexamethasone in patients with newly diagnosed iMCD.

Hao Zhao, Miao-Yan Zhang, Kai-Ni Shen

|Mar 29, 2021
Revealing serum lipidomic characteristics and potential lipid biomarkers in patients with POEMS syndrome.

Hao Zhao, Xue-Min Gao, Xin-Xin Cao

Pageof 1

Frequent Collaborators

3 joint publications

Miao-Yan Zhang

3 joint publications

Lu Zhang

3 joint publications

Jian Li

2 joint publications

Ming-Hui Duan